View Older Stories

May 8, 2026 04:54AM Lantheus Holdings (LNTH) PT Raised to $115 at Citizens AFter Q1 Results

May 7, 2026 07:07AM Lantheus Holdings (LNTH) Tops Q1 EPS by 23c, Beats on Revenue; Offers FY26 Guidance

Apr 9, 2026 04:05PM Lantheus Holdings (LNTH) PT Raised to $96 at Brookline Capital Markets

Mar 18, 2026 05:19AM Citizens Reiterates Market Outperform Rating on Lantheus Holdings (LNTH)

Mar 17, 2026 05:13PM William Blair on Lantheus Holdings (LNTH) following PDUFA date extended: 'optimistic' co will receive approval

Mar 17, 2026 03:08PM Lantheus Holdings (LNTH) PT Raised to $110 at Jefferies

Mar 9, 2026 05:41AM Lantheus Holdings (LNTH) Reiterated at Market Outperform by Citizens: Stock Inexpensive

Mar 2, 2026 08:32AM Lantheus receives FDA tentative approval for generic cancer drug

Feb 27, 2026 12:04PM Lantheus Holdings (LNTH) PT Raised to $89 at Truist Securities

Feb 27, 2026 04:30AM Lantheus Holdings (LNTH) PT Raised to $85 at Citizens After Q4 Sales, EPS Beats

Feb 26, 2026 04:25PM Jones Trading Downgrades Lantheus Holdings (LNTH) to Hold

Feb 26, 2026 11:50AM William Blair Upgrades Lantheus Holdings (LNTH) to Outperform

Feb 9, 2026 06:24AM Lantheus Holdings (LNTH) PT Raised to $94 at Leerink Partners

Jan 2, 2026 08:00AM Lantheus completes sale of SPECT business to SHINE Technologies

Dec 11, 2025 04:30PM Truist Securities Upgrades Lantheus Holdings (LNTH) to Buy

Dec 7, 2025 11:21AM Grabar Law Office Investigates Claims on Behalf of Long-Term Shareholders of Lantheus Holdings, Inc. (LNTH)

Nov 12, 2025 09:20AM Lantheus Holdings (LNTH) PT Lowered to $90 at Leerink Partners

Oct 30, 2025 08:31AM Lantheus receives FDA PDUFA date of March 29, 2026 for NET imaging kit

Oct 28, 2025 08:33AM FDA accepts Lantheus application for Alzheimer's tau imaging agent

Oct 8, 2025 04:40AM Goldman Sachs Downgrades Lantheus Holdings (LNTH) to Neutral

Sep 24, 2025 04:51AM Lantheus licenses prostate cancer imaging agent to GE HealthCare for Japan

Sep 15, 2025 09:13AM Lantheus Holdings (LNTH) PT Lowered to $80 at TD Cowen

Aug 21, 2025 05:34AM Lantheus Holdings (LNTH) PT Lowered to $99 at Leerink Partners

Aug 11, 2025 04:17PM Truist Securities Downgrades Lantheus Holdings (LNTH) to Hold

Aug 7, 2025 04:03PM Lantheus Holdings (LNTH) PT Lowered to $110 at Goldman Sachs

Aug 7, 2025 05:04AM Lantheus Holdings (LNTH) call put ratio 4.6 calls to 1 put with a focus on September 50 calls

Aug 7, 2025 04:16AM Lantheus Holdings (LNTH) PT Lowered to $73 at Citizens JMP

Aug 6, 2025 07:59AM Lantheus Holdings (LNTH) Misses Q2 EPS by 10c ; Offers Guidance

Aug 6, 2025 06:45AM Lantheus gets FDA acceptance for new PSMA imaging agent formulation

Jul 22, 2025 09:13AM Lantheus completes Life Molecular Imaging acquisition, names new R&D head

Jul 22, 2025 08:55AM Lantheus completes Life Molecular Imaging acquisition

May 8, 2025 08:13AM Truist Spots Opportunity in Lantheus (LNTH) Sell-Off Despite Lower Price Target

May 6, 2025 04:01PM Lantheus Holdings (LNTH) Announces Sale of SPECT Business to SHINE Technologies

May 6, 2025 05:45AM Lantheus Holdings (LNTH) May 90 and 100 puts active

Apr 30, 2025 08:30AM Lantheus Holdings (LNTH) Announces MK-6240 Meets Co-Primary Endpoints in Two Pivotal Studies

Apr 1, 2025 09:01AM Lantheus Holdings (LNTH) Completes Acquisition of Evergreen Theragnostics

Feb 27, 2025 06:11AM Lantheus Holdings (LNTH) PT Lowered to $140 at Mizuho

Feb 26, 2025 07:14AM Lantheus Holdings (LNTH) Tops Q4 EPS by 4c ; Offers Guidance

Feb 15, 2025 10:00PM Biotech Q4 earnings preview: Goldman Sachs

Jan 30, 2025 08:32AM Lantheus Holdings (LNTH) Appoints Phuong Khanh Morrow to its Board

Jan 28, 2025 06:15AM Lantheus Holdings (LNTH) to Acquire Evergreen Theragnostics for Upfront Payment of $250M

Jan 21, 2025 06:00PM MedTech sector outlook for 2025: Truist Securities

Jan 13, 2025 12:08AM Lantheus Holdings (LNTH) o Acquire Life Molecular Imaging for an Upfront Payment of $350 Million

Dec 18, 2024 04:12AM Goldman Sachs Starts Lantheus Holdings (LNTH) at Buy

Nov 20, 2024 06:25AM Lantheus Holdings (LNTH) Announces $250M Share Buyback

Nov 11, 2024 02:33PM TD Cowen Reiterates Buy Rating on Lantheus Holdings (LNTH)

Nov 11, 2024 07:41AM Lantheus Holdings (LNTH) Continues to Commend CMS’ CY25 Rule to Enhance Payment for Specialized Diagnostic Radiopharmaceuticals and Reaffirms Outlook for PYLARIFY’s Blockbuster Status for 2025

Nov 7, 2024 05:58AM Lantheus Holdings (LNTH) PT Lowered to $122 at Leerink Partners

Nov 6, 2024 08:37AM Lantheus Holdings (LNTH) Tops Q3 EPS by 14c; offers guidance

Sep 30, 2024 03:11PM Truist Securities Reiterates Buy Rating on Lantheus Holdings (LNTH)

View Older Stories